1 신소영, "급성백혈병 완전 관해 골수에서 항원형 이상 세포의 분포" 대한진단검사의학회 28 (28): 1-7, 2008
2 Al-Mawali A, "The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia" 131 : 16-26, 2009
3 Buccisano F, "The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia" 20 : 1783-1789, 2006
4 Chung NG, "The detection and significance of minimal residual disease in acute and chronic leukemia" 68 : 371-385, 2006
5 Campana D, "Status of minimal residual disease testing in childhood haematological malignancies" 143 : 481-489, 2008
6 Ciudad J, "Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia" 16 : 3774-3781, 1998
7 Dworzak MN, "Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia" 99 : 1952-1958, 2002
8 Coustan-Smith E, "Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lym phoblastic leukemia" 100 : 52-58, 2002
9 Kern W, "Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia" 89 : 528-540, 2004
10 Kern W, "Monitoring of minimal residual disease in acute myeloid leukemia" 112 : 4-16, 2008
1 신소영, "급성백혈병 완전 관해 골수에서 항원형 이상 세포의 분포" 대한진단검사의학회 28 (28): 1-7, 2008
2 Al-Mawali A, "The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia" 131 : 16-26, 2009
3 Buccisano F, "The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia" 20 : 1783-1789, 2006
4 Chung NG, "The detection and significance of minimal residual disease in acute and chronic leukemia" 68 : 371-385, 2006
5 Campana D, "Status of minimal residual disease testing in childhood haematological malignancies" 143 : 481-489, 2008
6 Ciudad J, "Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia" 16 : 3774-3781, 1998
7 Dworzak MN, "Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia" 99 : 1952-1958, 2002
8 Coustan-Smith E, "Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lym phoblastic leukemia" 100 : 52-58, 2002
9 Kern W, "Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia" 89 : 528-540, 2004
10 Kern W, "Monitoring of minimal residual disease in acute myeloid leukemia" 112 : 4-16, 2008
11 Vidriales MB, "Minimal residual disease monitoring by flow cytometry" 16 : 599-612, 2003
12 Feller N, "MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia" 18 : 1380-1390, 2004
13 Venditti A, "Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia" 96 : 3948-3952, 2000
14 San Miguel JF, "Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients" 90 : 2465-2470, 1997
15 Plata E, "Flowcytometric detection of minimal residual disease with atypical antigen combinations in patients with de novo acute myeloid leukemia" 79 : 543-546, 2000
16 San Miguel JF, "Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification" 98 : 1746-1751, 2001
17 Kern W, "Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia" 104 : 3078-3085, 2004
18 Kern W, "Detection of minimal residual disease in unselected patients with acute myeloid leukemia using multiparameter flow cytometry for definition of leukemia-associated immunophenotypes and determination of their frequencies in normal bone marrow" 88 : 646-653, 2003
19 Mrozek K, "Cytogenetics in acute leukemia" 18 : 115-136, 2004
20 Coustan-Smith E, "Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia" 123 : 243-252, 2003
21 Borowitz MJ, "Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study" 111 : 5477-5485, 2008
22 Coustan-Smith E, "Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia after first relapse" 18 : 499-504, 2004
23 Venditti A, "Clinical relevance of minimal residual disease detection in adult acute myeloid leukemia" 11 : 349-357, 2002
24 Coustan-Smith E, "Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia" 96 : 2691-2696, 2000
25 Coustan-Smith E, "A simplified flow cytometric assay identifies children with acute lymphoblastic leukemia who have a superior clinical outcome" 108 : 97-102, 2006